Letrovitae Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

Full Prescribing Info

Description

Each film-coated tablet contains 2.5 mg letrozole.
Excipients/Inactive Ingredients: Each tablet contains 45 mg of lactose monohydrate (see Precautions).
Tablet core: Lactose monohydrate, Carboxymethylstarch sodium (type A) (from potato starch), Microcrystalline cellulose, Hypromellose, Colloidal anhydrous silica and Magnesium stearate.
Coating: Yellow Opadry consisting of: Hypromellose, Macrogol 6000, Titanium dioxide (E171), Yellow iron oxide (E172), Red iron oxide (E172) and tartrazine (E102).

letrozole

Manufacturer:

Pacific Healthcare

Distributor:

Pacific Healthcare